UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 495

Sortiert nach

A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials

Diabetes, obesity & metabolism, 2019-01, Vol.21 (1), p.120-128

2019

Volltextzugriff (PDF)

Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects

PloS one, 2011-12, Vol.6 (12), p.e28872-e28872

2011

Volltextzugriff (PDF)

Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload

PloS one, 2009-08, Vol.4 (8), p.e6743-e6743

2009

Volltextzugriff (PDF)

Outer membrane vesicles of Tannerella forsythia: biogenesis, composition, and virulence

Molecular oral microbiology, 2015-12, Vol.30 (6), p.451-473

2015

Volltextzugriff (PDF)

A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects

Journal of medical genetics, 2010-04, Vol.47 (4), p.230-235

2010

Volltextzugriff (PDF)

Potential of the Tannerella forsythia S-layer to Delay the Immune Response

Journal of dental research, 2011-01, Vol.90 (1), p.109-114

2011

Volltextzugriff (PDF)

Depression, anxiety, and quality of life as predictors of rehospitalization in patients with chronic heart failure

BMC cardiovascular disorders, 2023-10, Vol.23 (1), p.1-525, Article 525

2023

Volltextzugriff (PDF)

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy

Human molecular genetics, 2008-09, Vol.17 (18), p.2753-2765

2008

Volltextzugriff (PDF)

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

The Lancet (British edition), 2018-06, Vol.391 (10140), p.2607-2618

2018

Volltextzugriff (PDF)

Einfluss der Schweißparameter auf das Ermüdungsverhalten hochfester Baustähle

Materialwissenschaft und Werkstofftechnik, 2013-11, Vol.44 (11), p.889-896

2013

Volltextzugriff (PDF)

MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study

British journal of clinical pharmacology, 2018-10, Vol.84 (10), p.2325-2335

2018

Volltextzugriff (PDF)

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study

Diabetes care, 2022-09, Vol.45 (9), p.2118-2126

2022

Volltextzugriff (PDF)

Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist

The journal of clinical endocrinology and metabolism, 2020-03, Vol.105 (3), p.803-820

2020

Volltextzugriff (PDF)

Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study

ACR open rheumatology, 2022-10, Vol.4 (10), p.903-911

2022

Volltextzugriff (PDF)

An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis

Journal of the American Academy of Dermatology, 2022-11, Vol.87 (5), p.1089-1091

2022

Volltextzugriff (PDF)

Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease

Diabetes, obesity & metabolism, 2022-07, Vol.24 (7), p.1360-1369

2022

Volltextzugriff (PDF)

Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes

Heart rhythm, 2009-04, Vol.6 (4), p.480-486

2009

Volltextzugriff (PDF)

Subacute Coronary Stent Thrombosis in Cancer Patients

Journal of the American College of Cardiology, 2008-03, Vol.51 (12), p.1232-1233

2008

Volltextzugriff (PDF)

First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults

European journal of drug metabolism and pharmacokinetics, 2023-09, Vol.48 (5), p.553-566

2023

Volltextzugriff (PDF)

674-P: Efficacy and Safety of Cotadutide, a Dual GLP-1 and Glucagon Receptor Agonist in Patients with T2DM and DKD

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4

PloS one, 2011-06, Vol.6 (6), p.e20711-e20711

2011

Volltextzugriff (PDF)

Welding of railway wagons: tasks in the area of materials, processes and automation

Welding international, 2015-03, Vol.29 (3), p.213-218

2015

Volltextzugriff (PDF)

Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series

European heart journal : case reports, 2019-09, Vol.3 (3)

2019

Volltextzugriff (PDF)

Molecular genetics of congenital atrial septal defects

Clinical research in cardiology, 2010-03, Vol.99 (3), p.137-147

2010

Volltextzugriff (PDF)

1 – 25 von 495

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(439)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials

Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects

Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload

Outer membrane vesicles of Tannerella forsythia: biogenesis, composition, and virulence

A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects

Potential of the Tannerella forsythia S-layer to Delay the Immune Response

Depression, anxiety, and quality of life as predictors of rehospitalization in patients with chronic heart failure

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

Einfluss der Schweißparameter auf das Ermüdungsverhalten hochfester Baustähle

MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study

Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist

Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study

An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis

Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease

Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes

Subacute Coronary Stent Thrombosis in Cancer Patients

First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults

674-P: Efficacy and Safety of Cotadutide, a Dual GLP-1 and Glucagon Receptor Agonist in Patients with T2DM and DKD

Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study

Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4

Welding of railway wagons: tasks in the area of materials, processes and automation

Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series

Molecular genetics of congenital atrial septal defects

Suchergebnisse filtern